561 related articles for article (PubMed ID: 11192876)
1. Distortion-product otoacoustic emissions and glycerol testing in endolymphatic hydrops.
Magliulo G; Cianfrone G; Triches L; Altissimi G; D'Amico R
Laryngoscope; 2001 Jan; 111(1):102-9. PubMed ID: 11192876
[TBL] [Abstract][Full Text] [Related]
2. Early diagnosis of endolymphatic hydrops with distortion. Product otoacoustic emissions.
Magliulo G; Cianfrone G; Di Cello P; Tersigni A
An Otorrinolaringol Ibero Am; 2004; 31(2):173-89. PubMed ID: 15185614
[TBL] [Abstract][Full Text] [Related]
3. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
Fetterman BL
Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
[TBL] [Abstract][Full Text] [Related]
4. Vestibular evoked myogenic potentials and glycerol testing.
Magliulo G; Cuiuli G; Gagliardi M; Ciniglio-Appiani G; D'Amico R
Laryngoscope; 2004 Feb; 114(2):338-43. PubMed ID: 14755215
[TBL] [Abstract][Full Text] [Related]
5. Changes in input/output function of distortion product otoacoustic emissions during the glycerol test in Ménière's disease.
Sakashita T; Shibata T; Yamane H; Hikawa C
Acta Otolaryngol Suppl; 2004 Oct; (554):26-9. PubMed ID: 15513506
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous otoacoustic emissions in humans with endolymphatic hydrops.
Haginomori SI; Makimoto K; Tanaka H; Araki M; Takenaka H
Laryngoscope; 2001 Jan; 111(1):96-101. PubMed ID: 11192908
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of glycerol test in Meniere's disease with pure tone audiometry and distortion product otoacoustic emission].
Jabłonka A; Pośpiech L; Orendorz-Fraczkowska K
Otolaryngol Pol; 2003; 57(5):731-7. PubMed ID: 14994621
[TBL] [Abstract][Full Text] [Related]
8. Vestibular evoked myogenic potentials and distortion-product otoacoustic emissions combined with glycerol testing in endolymphatic hydrops: their value in early diagnosis.
Magliulo G; Cianfrone G; Gagliardi M; Cuiuli G; D'Amico R
Ann Otol Rhinol Laryngol; 2004 Dec; 113(12):1000-5. PubMed ID: 15633904
[TBL] [Abstract][Full Text] [Related]
9. [Changes in otoacoustic emission during the glycerol test in the ears of patients with Meniere's disease].
Sakashita T; Kubo T; Kyunai K; Ueno K; Hikawa C; Shibata T; Yamane H; Kusuki M; Wada T; Uyama T
Nihon Jibiinkoka Gakkai Kaiho; 2001 Jun; 104(6):682-93. PubMed ID: 11494522
[TBL] [Abstract][Full Text] [Related]
10. Clinical application of transiently evoked otoacoustic emissions after glycerol administration for diagnosis of sensorineural hearing loss.
Inoue Y; Kanzaki J; O-Uchi T; Ogawa K; Ogata A; Yoshihara S; Satoh Y
Auris Nasus Larynx; 1997 Apr; 24(2):143-9. PubMed ID: 9134136
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
12. Visualization of endolymphatic hydrops and correlation with audio-vestibular functional testing in patients with definite Meniere's disease.
Seo YJ; Kim J; Choi JY; Lee WS
Auris Nasus Larynx; 2013 Apr; 40(2):167-72. PubMed ID: 22867525
[TBL] [Abstract][Full Text] [Related]
13. [Aural fullness and endolymphatic hydrops].
Gossow-Müller-Hohenstein E; Hirschfelder A; Scholz G; Mrowinski D
Laryngorhinootologie; 2003 Feb; 82(2):97-101. PubMed ID: 12624836
[TBL] [Abstract][Full Text] [Related]
14. A Comparison of Distortion Product Otoacoustic Emission Properties in Ménière's Disease Patients and Normal-Hearing Participants.
Drexl M; Krause E; Gürkov R
Ear Hear; 2018; 39(1):42-47. PubMed ID: 28671918
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of vestibular evoked myogenic potentials: an indication for distended saccular hydrops.
Young YH; Wu CC; Wu CH
Laryngoscope; 2002 Mar; 112(3):509-12. PubMed ID: 12148863
[TBL] [Abstract][Full Text] [Related]
16. Cochlear microphonics in Ménière's disease.
Ge NN; Shea JJ; Orchik DJ
Am J Otol; 1997 Jan; 18(1):58-66. PubMed ID: 8989953
[TBL] [Abstract][Full Text] [Related]
17. Summating potential and action potential ratio in Meniere's disease before and after treatment.
Orchik DJ; Shea JJ; Ge NN
Am J Otol; 1998 Jul; 19(4):478-82; discussion 483. PubMed ID: 9661758
[TBL] [Abstract][Full Text] [Related]
18. Patterns of change in growth function of distortion product otoacoustic emissions in Menière's disease.
Sakashita T; Kubo T; Kusuki M; Kyunai K; Ueno K; Hikawa C; Wada T; Shibata T; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():70-7. PubMed ID: 9879405
[TBL] [Abstract][Full Text] [Related]
19. On the differential diagnosis of Ménière's disease using low-frequency acoustic biasing of the 2f1-f2 DPOAE.
Brown DJ; Gibson WP
Hear Res; 2011 Dec; 282(1-2):119-27. PubMed ID: 21944944
[TBL] [Abstract][Full Text] [Related]
20. Abnormal fast fluctuations of electrocochleography and otoacoustic emissions in Menière's disease.
Gerenton G; Giraudet F; Djennaoui I; Pavier Y; Gilain L; Mom T; Avan P
Hear Res; 2015 Sep; 327():199-208. PubMed ID: 26232527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
